Dino Mehic/LinkedIn
Dec 14, 2025, 13:14
Dino Mehic with Colleagues: BDUC – What is It and What Do We Know?
Dino Mehic, Physician Scientist at the Medical University of Vienna, shared on LinkedIn:
“Bleeding Disorder of Unknown Cause (BDUC): What Do We Know?
- We are excited to share that we recently summarized nearly two decades of clinical and research experience in the management of patients with bleeding disorders of unknown cause (BDUC).
- This review represents a long-standing, collaborative effort to better understand the natural history of BDUC led by Ingrid Pabinger, Johanna Gebhart, and Cihan Ay at our institution (Medical University of Vienna).
- At the American Society of Hematology 2025 Annual Meeting in Orlando, Prof. Pabinger presented our current understanding of how to predict and treat BDUC-an important step toward improving care for this under-recognized patient population.
Title: Predictors for future bleeding in bleeding disorder of unknown cause
Authors: Tim Dreier, Dino Mehic, Cihan Ay, Johanna Gebhart, Ingrid Pabinger

Link to the publication in ASH Hematology”
Stay informed with ASH2025 updates on Hemostasis Today.
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria